Platelet activation: ultrastructure and morphometry in platelet-rich plasma of horses

Detalhes bibliográficos
Autor(a) principal: Zandim,Bruna M.
Data de Publicação: 2012
Outros Autores: Souza,Maria V. de, Magalhães,Pablo C., Benjamin,Laércio dos A., Maia,Leandro, Oliveira,Aécio C. de, Pinto,José de O., Ribeiro Júnior,José I.
Tipo de documento: Relatório
Idioma: eng
Título da fonte: Pesquisa Veterinária Brasileira (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-736X2012000100014
Resumo: This study was conducted to investigate the activation ability of the platelet-rich plasma (PRP) by pharmacological agents, as well as to verify the need or not of this activation for therapeutic use. The PRP was obtained from four healthy crossbred geldings aged 13 to 16 years (15±1years), and was processed for observation and quantification of the platelet morphology by using the transmission electron microscopy. All PRP samples were activated with 10% calcium chloride (CaCl2) solution, pure bovine thrombin or associated with CaCl2. The control (pure PRP) was not pharmacologically activated. In the pure PRP samples, 49% of the platelets were classified as state of activation uncertain, 41% as resting, 9% as fully activated and 1% as irreversibly damaged. Treatment with 10% CaCl2 provided a distribution of 54% platelets in state of activation uncertain, 24% as fully activated, 20% as resting, and 2% as irreversibly damaged. The platelet morphology of the bovine thrombin treated samples did not fit into classification adopted, as showing irregular shape with emission of large filamentous pseudopods, appearance of ruptured and whole granules in the remaining cytoplasm and extracellular environment. There was effect of the treatment on the platelet morphology (P=0.03). The 10% CaCl2 is an adequate platelet-activating agent. However, in cases the use of PRP under its liquid form is necessary, the use of pure PRP is recommended, since besides presenting an adequate percentage of fully activated platelets it also has significant amount of the resting type, which can be activated by substances found in the injured tissue.
id EMBRAPA-2_40f7ae31ac99a83303236b9f5d60f52c
oai_identifier_str oai:scielo:S0100-736X2012000100014
network_acronym_str EMBRAPA-2
network_name_str Pesquisa Veterinária Brasileira (Online)
repository_id_str
spelling Platelet activation: ultrastructure and morphometry in platelet-rich plasma of horsesPlasma rich in plateletsplatelet functiongrowth factorshorsesThis study was conducted to investigate the activation ability of the platelet-rich plasma (PRP) by pharmacological agents, as well as to verify the need or not of this activation for therapeutic use. The PRP was obtained from four healthy crossbred geldings aged 13 to 16 years (15±1years), and was processed for observation and quantification of the platelet morphology by using the transmission electron microscopy. All PRP samples were activated with 10% calcium chloride (CaCl2) solution, pure bovine thrombin or associated with CaCl2. The control (pure PRP) was not pharmacologically activated. In the pure PRP samples, 49% of the platelets were classified as state of activation uncertain, 41% as resting, 9% as fully activated and 1% as irreversibly damaged. Treatment with 10% CaCl2 provided a distribution of 54% platelets in state of activation uncertain, 24% as fully activated, 20% as resting, and 2% as irreversibly damaged. The platelet morphology of the bovine thrombin treated samples did not fit into classification adopted, as showing irregular shape with emission of large filamentous pseudopods, appearance of ruptured and whole granules in the remaining cytoplasm and extracellular environment. There was effect of the treatment on the platelet morphology (P=0.03). The 10% CaCl2 is an adequate platelet-activating agent. However, in cases the use of PRP under its liquid form is necessary, the use of pure PRP is recommended, since besides presenting an adequate percentage of fully activated platelets it also has significant amount of the resting type, which can be activated by substances found in the injured tissue.Colégio Brasileiro de Patologia Animal - CBPA2012-01-01info:eu-repo/semantics/reportinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-736X2012000100014Pesquisa Veterinária Brasileira v.32 n.1 2012reponame:Pesquisa Veterinária Brasileira (Online)instname:Colégio Brasileiro de Patologia Animal (CBPA)instacron:EMBRAPA10.1590/S0100-736X2012000100014info:eu-repo/semantics/openAccessZandim,Bruna M.Souza,Maria V. deMagalhães,Pablo C.Benjamin,Laércio dos A.Maia,LeandroOliveira,Aécio C. dePinto,José de O.Ribeiro Júnior,José I.eng2012-02-14T00:00:00Zoai:scielo:S0100-736X2012000100014Revistahttp://www.pvb.com.br/https://old.scielo.br/oai/scielo-oai.phpcolegio@cbpa.org.br||pvb@pvb.com.br0100-736X1678-5150opendoar:2012-02-14T00:00Pesquisa Veterinária Brasileira (Online) - Colégio Brasileiro de Patologia Animal (CBPA)false
dc.title.none.fl_str_mv Platelet activation: ultrastructure and morphometry in platelet-rich plasma of horses
title Platelet activation: ultrastructure and morphometry in platelet-rich plasma of horses
spellingShingle Platelet activation: ultrastructure and morphometry in platelet-rich plasma of horses
Zandim,Bruna M.
Plasma rich in platelets
platelet function
growth factors
horses
title_short Platelet activation: ultrastructure and morphometry in platelet-rich plasma of horses
title_full Platelet activation: ultrastructure and morphometry in platelet-rich plasma of horses
title_fullStr Platelet activation: ultrastructure and morphometry in platelet-rich plasma of horses
title_full_unstemmed Platelet activation: ultrastructure and morphometry in platelet-rich plasma of horses
title_sort Platelet activation: ultrastructure and morphometry in platelet-rich plasma of horses
author Zandim,Bruna M.
author_facet Zandim,Bruna M.
Souza,Maria V. de
Magalhães,Pablo C.
Benjamin,Laércio dos A.
Maia,Leandro
Oliveira,Aécio C. de
Pinto,José de O.
Ribeiro Júnior,José I.
author_role author
author2 Souza,Maria V. de
Magalhães,Pablo C.
Benjamin,Laércio dos A.
Maia,Leandro
Oliveira,Aécio C. de
Pinto,José de O.
Ribeiro Júnior,José I.
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Zandim,Bruna M.
Souza,Maria V. de
Magalhães,Pablo C.
Benjamin,Laércio dos A.
Maia,Leandro
Oliveira,Aécio C. de
Pinto,José de O.
Ribeiro Júnior,José I.
dc.subject.por.fl_str_mv Plasma rich in platelets
platelet function
growth factors
horses
topic Plasma rich in platelets
platelet function
growth factors
horses
description This study was conducted to investigate the activation ability of the platelet-rich plasma (PRP) by pharmacological agents, as well as to verify the need or not of this activation for therapeutic use. The PRP was obtained from four healthy crossbred geldings aged 13 to 16 years (15±1years), and was processed for observation and quantification of the platelet morphology by using the transmission electron microscopy. All PRP samples were activated with 10% calcium chloride (CaCl2) solution, pure bovine thrombin or associated with CaCl2. The control (pure PRP) was not pharmacologically activated. In the pure PRP samples, 49% of the platelets were classified as state of activation uncertain, 41% as resting, 9% as fully activated and 1% as irreversibly damaged. Treatment with 10% CaCl2 provided a distribution of 54% platelets in state of activation uncertain, 24% as fully activated, 20% as resting, and 2% as irreversibly damaged. The platelet morphology of the bovine thrombin treated samples did not fit into classification adopted, as showing irregular shape with emission of large filamentous pseudopods, appearance of ruptured and whole granules in the remaining cytoplasm and extracellular environment. There was effect of the treatment on the platelet morphology (P=0.03). The 10% CaCl2 is an adequate platelet-activating agent. However, in cases the use of PRP under its liquid form is necessary, the use of pure PRP is recommended, since besides presenting an adequate percentage of fully activated platelets it also has significant amount of the resting type, which can be activated by substances found in the injured tissue.
publishDate 2012
dc.date.none.fl_str_mv 2012-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/report
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format report
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-736X2012000100014
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-736X2012000100014
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0100-736X2012000100014
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Colégio Brasileiro de Patologia Animal - CBPA
publisher.none.fl_str_mv Colégio Brasileiro de Patologia Animal - CBPA
dc.source.none.fl_str_mv Pesquisa Veterinária Brasileira v.32 n.1 2012
reponame:Pesquisa Veterinária Brasileira (Online)
instname:Colégio Brasileiro de Patologia Animal (CBPA)
instacron:EMBRAPA
instname_str Colégio Brasileiro de Patologia Animal (CBPA)
instacron_str EMBRAPA
institution EMBRAPA
reponame_str Pesquisa Veterinária Brasileira (Online)
collection Pesquisa Veterinária Brasileira (Online)
repository.name.fl_str_mv Pesquisa Veterinária Brasileira (Online) - Colégio Brasileiro de Patologia Animal (CBPA)
repository.mail.fl_str_mv colegio@cbpa.org.br||pvb@pvb.com.br
_version_ 1754122231787552768